Cargando…
Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
The Ki‐67 proliferation index (PI) is a prognostic factor in neuroendocrine tumors (NETs) and defines tumor grade. Analysis of Ki‐67 PI requires calculation of Ki‐67‐positive and Ki‐67‐negative tumor cells, which is highly subjective. To overcome this, we developed a deep learning‐based Ki‐67 PI alg...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299468/ https://www.ncbi.nlm.nih.gov/pubmed/34741788 http://dx.doi.org/10.1111/apm.13190 |
_version_ | 1784750982406602752 |
---|---|
author | Vesterinen, Tiina Säilä, Jenni Blom, Sami Pennanen, Mirkka Leijon, Helena Arola, Johanna |
author_facet | Vesterinen, Tiina Säilä, Jenni Blom, Sami Pennanen, Mirkka Leijon, Helena Arola, Johanna |
author_sort | Vesterinen, Tiina |
collection | PubMed |
description | The Ki‐67 proliferation index (PI) is a prognostic factor in neuroendocrine tumors (NETs) and defines tumor grade. Analysis of Ki‐67 PI requires calculation of Ki‐67‐positive and Ki‐67‐negative tumor cells, which is highly subjective. To overcome this, we developed a deep learning‐based Ki‐67 PI algorithm (KAI) that objectively calculates Ki‐67 PI. Our study material consisted of NETs divided into training (n = 39), testing (n = 124), and validation (n = 60) series. All slides were digitized and processed in the Aiforia(®) Create (Aiforia Technologies, Helsinki, Finland) platform. The ICC between the pathologists and the KAI was 0.89. In 46% of the tumors, the Ki‐67 PIs calculated by the pathologists and the KAI were the same. In 12% of the tumors, the Ki‐67 PI calculated by the KAI was 1% lower and in 42% of the tumors on average 3% higher. The DL‐based Ki‐67 PI algorithm yields results similar to human observers. While the algorithm cannot replace the pathologist, it can assist in the laborious Ki‐67 PI assessment of NETs. In the future, this approach could be useful in, for example, multi‐center clinical trials where objective estimation of Ki‐67 PI is crucial. |
format | Online Article Text |
id | pubmed-9299468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92994682022-07-21 Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning Vesterinen, Tiina Säilä, Jenni Blom, Sami Pennanen, Mirkka Leijon, Helena Arola, Johanna APMIS Original Articles The Ki‐67 proliferation index (PI) is a prognostic factor in neuroendocrine tumors (NETs) and defines tumor grade. Analysis of Ki‐67 PI requires calculation of Ki‐67‐positive and Ki‐67‐negative tumor cells, which is highly subjective. To overcome this, we developed a deep learning‐based Ki‐67 PI algorithm (KAI) that objectively calculates Ki‐67 PI. Our study material consisted of NETs divided into training (n = 39), testing (n = 124), and validation (n = 60) series. All slides were digitized and processed in the Aiforia(®) Create (Aiforia Technologies, Helsinki, Finland) platform. The ICC between the pathologists and the KAI was 0.89. In 46% of the tumors, the Ki‐67 PIs calculated by the pathologists and the KAI were the same. In 12% of the tumors, the Ki‐67 PI calculated by the KAI was 1% lower and in 42% of the tumors on average 3% higher. The DL‐based Ki‐67 PI algorithm yields results similar to human observers. While the algorithm cannot replace the pathologist, it can assist in the laborious Ki‐67 PI assessment of NETs. In the future, this approach could be useful in, for example, multi‐center clinical trials where objective estimation of Ki‐67 PI is crucial. John Wiley and Sons Inc. 2021-11-22 2022-01 /pmc/articles/PMC9299468/ /pubmed/34741788 http://dx.doi.org/10.1111/apm.13190 Text en © 2021 The Authors. APMIS published by John Wiley & Sons Ltd on behalf of Scandinavian Societies for Medical Microbiology and Pathology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Vesterinen, Tiina Säilä, Jenni Blom, Sami Pennanen, Mirkka Leijon, Helena Arola, Johanna Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning |
title | Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning |
title_full | Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning |
title_fullStr | Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning |
title_full_unstemmed | Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning |
title_short | Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning |
title_sort | automated assessment of ki‐67 proliferation index in neuroendocrine tumors by deep learning |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299468/ https://www.ncbi.nlm.nih.gov/pubmed/34741788 http://dx.doi.org/10.1111/apm.13190 |
work_keys_str_mv | AT vesterinentiina automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning AT sailajenni automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning AT blomsami automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning AT pennanenmirkka automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning AT leijonhelena automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning AT arolajohanna automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning |